drugset / Trial / NCT03679845
Study to Assess Sarilumab in Halting Progression of Morphea
NaSingle-groupOpen-labelTreatment
Summary
An open-label single center trial studying the efficacy and safety of sarilumab on morphea patients.
Timeline
- Start
- 2019-09-01
- Primary completion
- 2021-06-30
- Completion
- 2021-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sarilumab | Monoclonal antibody | 200 mg | — |